Navigation Links
KaloBios Provides Update on KB001-A Partnership and Clinical Status
Date:7/28/2014

e, and represented the primary efficacy data included in the Sanofi Pasteur regulatory submission under which the VAP indication received Fast Track Status from the FDA. In a separate Phase 1/2 study conducted with CF patients, KaloBios showed a trend towards a dose-dependent reduction in several key inflammatory markers, including neutrophil elastase, when measured 28 days after a single dose of KB001. The results of this study were published in Pediatric Pulmonology.  KaloBios is currently conducting a 180 patient Phase 2 study of KB001-A in CF subjects with chronic Pa lung infection. 

Conference Call with Management
Management will host a teleconference and webcast to discuss plans for KB001-A in light of the updates on the KB001-A program on July 28, 2014, at 5:00PM Eastern Time (2:00PM Pacific Time).

Interested parties can listen to the live teleconference by dialing (800) 514-4861 from the United States and Canada or +1 (678) 809-2405 for international callers. The conference I.D. Code is 80897245.  Individuals may access the live audio webcast by visiting the event URL at: http://ir.kalobios.com/events.cfm.  A replay of the webcast will be available on the Company's website for six months following the live event.

About KaloBios
KaloBios Pharmaceuticals, Inc. is developing a portfolio of proprietary, patient-targeted, first-in-class monoclonal antibodies designed to treat severe life-threatening or debilitating diseases for which there is an unmet medical need, with a clinical focus on severe respiratory diseases and cancer.

Currently, KaloBios has advanced three programs to clinical development:

  • KB001-A is an anti-PcrV mAb fragment being developed for the prevention and treatment of '/>"/>

SOURCE KaloBios Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. KaloBios Pharmaceuticals Announces Pricing of Initial Public Offering
2. KaloBios Pharmaceuticals Completes Initial Public Offering
3. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
4. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma
5. Bioassociate Announces Initiation of Coverage on KaloBios Pharmaceuticals, Inc.
6. KaloBios to Present at Future Leaders in the Biotech Industry Conference
7. KaloBios Targeted Antibacterial KB001-A to be Featured in BIO 2013 Panel Discussion of "New Defenses Against Old Enemies"
8. KaloBios to Present at Needham Healthcare Conference
9. KaloBios Reports First Quarter 2013 Financial Results
10. KaloBios to Present at Stifel Healthcare Conference 2013
11. KaloBios KB001 Anti-Pseudomonas Antibody Study Published in Pediatric Pulmonology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... PARIS and MOUNTAIN VIEW, Calif. ... (NYSE: SNY ; EURONEXT: SAN) and the life ... collaborating to improve care and outcomes for people with ... leadership in diabetes treatments and devices with Google,s expertise ... The companies will explore how to improve diabetes care ...
(Date:8/31/2015)... , Aug. 31, 2015  Asterias Biotherapeutics, Inc. ... the emerging field of regenerative medicine, today announced ... Chicago -based Rush University Medical ... activity of escalating doses of AST-OPC1 (oligodendrocyte progenitor ... motor complete cervical spinal cord injury (SCI). This ...
(Date:8/31/2015)...   BioLife Solutions , Inc. (NASDAQ: ... of proprietary clinical grade cell and tissue ... media and a related cloud hosted biologistics ... shippers ("BioLife" or the "Company"), today announced ... company focused on developing and commercializing novel therapeutics ...
Breaking Medicine Technology:Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5
(Date:8/31/2015)... ... August 31, 2015 , ... Since 1946, the doctors ... care. From the moment a patient arrives at the office, the staff will ... work with each and every patient to create a complete dental treatment plan that ...
(Date:8/31/2015)... ... , ... Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center is ... all surgical and non-surgical disorders of the leg, ankle and foot. He also ... spine. , Dr. Paul Kovatis completed his orthopedic leg, ankle and foot fellowship training ...
(Date:8/31/2015)... Nashville, TN (PRWEB) , ... August 31, 2015 , ... ... and how it may be prevented during Amblyopia Awareness Month. Only a comprehensive eye ... is the most common cause of visual impairment among children, affecting approximately 2 to ...
(Date:8/31/2015)... ... 2015 , ... According to an article published August 3rd on ... who underwent bariatric surgery “felt significantly better two years after surgery.” The article goes ... the study felt that their “mental health had been normalized” at the point when ...
(Date:8/31/2015)... ... August 31, 2015 , ... Nine innovative healthcare companies ... Innovations in Healthcare(SM) Awards Event , on October 21, 2015, in Long Beach. ... innovative organizations and individuals who are dramatically reducing the cost of quality healthcare. ...
Breaking Medicine News(10 mins):Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:NJ Top Docs Presents, Dr. Paul Kovatis of Orthopedic Spine & Sports Medicine Center on his Five Year Anniversary as an "NJ Top Doc" 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 2Health News:Article on Adolescent Bariatric Surgery Demonstrates the Powerful Effect of Being in Control, Notes Dr. Michael Feiz 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 2Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 3Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 4Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 5Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 6Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 7Health News:9 Finalists Named for Innovations in Healthcare(SM) ABBY Awards; Winners to be Chosen October 21 in Long Beach, CA 8
... Approximately 100 student,government leaders, representing more than ... Nashville Oct. 5-7 to discuss,healthcare issues under the ... engage young Americans in the debate over healthcare., ... Center, just blocks from,the Oct. 7 presidential debate ...
... CALDWELL, N.J., Sept. 17 Community,Education Centers, Inc. ... Department of Postsecondary Education held a dedication,ceremony for ... John J. Clancy, Chairman and CEO of CEC ... and Chancellor Bradley,Byrne, as well as over two ...
... Parents Dental Tips for Back-to-School, ROANOKE, Va., Sept. ... for parents to take a refresher course in their ... the U.S. Department of Health and,Human Services, students miss ... dental problems or related conditions. Dental pain can distract,your ...
... of Medicine have modified a honeybee venom toxin so that ... inner workings of ion channels that control heart rate and ... selectively allow the passage of small ions such as sodium, ... The study, published in the Proceedings of the National ...
... Fallon has presented Curemark,s most recent findings on autism at the ... 24-29 at Magdalene College in Oxford. , ... Rye, ... announced today that Founder and CEO Dr. Joan Fallon has presented ...
... American Kidney Fund today issued an urgent appeal for contributions for disaster ... , ... Rockville, MD (PRWEB) September 17, 2008 -- The American Kidney ... help dialysis patients who have been affected by Hurricane Ike. , , ...
Cached Medicine News:Health News:College Students Seek Healthcare Solutions on Eve of Debate 2Health News:Prisoner Reentry Facility Holds Dedication Ceremony 2Health News:Smart Minds Start With Healthy Mouths 2Health News:Smart Minds Start With Healthy Mouths 3Health News:Penn researchers use honeybee venom toxin to develop a new tool for studying hypertension 2Health News:Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 2Health News:American Kidney Fund Issues Appeal for Disaster Relief Contributions 3
... VACUETTE® erythrocyte sedimentation rate analysers, which ... new generation unites the well-established advantages ... range of additional innovations which guarantee ... sedimentation rate. Cost effectiveness is an ...
Blood sedimentation rate analysis...
Blood sedimentation rate analysis...
The Sedimat 15 Automated sedrate system provides an accurate ESR result in only 15 minutes. Fast, in-office results (before patient leaves the office) can lead to improved patient therapy....
Medicine Products: